Cargando…
Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease
Alanine–serine–cysteine transporter 2 (ASCT2) is reported to participate in the progression of tumors and metabolic diseases. It is also considered to play a crucial role in the glutamate-glutamine shuttle of neuroglial network. However, it remains unclear the involvement of ASCT2 in neurological di...
Autores principales: | Liu, Yang, Liu, Ting, Zhou, Yuanzhang, Li, Wenjie, Wang, Min, Song, Nanshan, Zhang, Wenbin, Jiang, Jingwei, Yuan, Shengtao, Ding, Jianhua, Hu, Gang, Lu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978855/ https://www.ncbi.nlm.nih.gov/pubmed/36873178 http://dx.doi.org/10.1016/j.apsb.2022.07.021 |
Ejemplares similares
-
Screening study for genetic polymorphisms affecting pharmacokinetics of talniflumate
por: Jin, Li Hua, et al.
Publicado: (2017) -
β-Arrestin2-biased Drd2 agonist UNC9995 alleviates astrocyte inflammatory injury via interaction between β-arrestin2 and STAT3 in mouse model of depression
por: Liu, Yang, et al.
Publicado: (2022) -
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer
por: Agostini, Antonio, et al.
Publicado: (2023) -
Mitochondrial translocator protein (TSPO), astrocytes and neuroinflammation
por: Chechneva, Olga V., et al.
Publicado: (2016) -
Bushen-Yizhi Formula Alleviates Neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson's Disease
por: Mo, Yousheng, et al.
Publicado: (2018)